Preclinical study of the thymoanaleptic effect of furylated dihydropyridine-2-thiol derivatives of alpha-cyanothioacetamide in a haloperidol catalepsy test
https://doi.org/10.18699/SSMJ20250213
Abstract
Over the past decades, there has been a steady increase in the incidence of depressive disorders. Modern antidepressants predominantly are drugs with a high incidence of side effects and drug interactions. The aim of the study is to investigate the thymoanaleptic effect of new substances of the substituted furylated nitrogen-containing heterocyclic derivatives of alpha-cyanothioacetamide in the haloperidol-induced catalepsy test.
Material and methods. The experiments were performed on 110 animals divided into 11 groups: a control group, two comparison groups (comparison drugs – amitriptyline and fluoxetine), eight experimental groups (respectively, eight experimental samples). In the haloperidolinduced catalepsy test, the effectiveness of furylated dihydropyridine-2-thiols with codes d02-20, CV-103, AZ-381, AZ-127, d02-26, CV-133, AZ-618, AZ-128, which have already shown thymoanaleptic properties in the tail suspension and forced swimming tests, as well as anxiolytic properties in the dark-light chamber test, was studied.
Results and discussion. Fluoxetine was more effective in eliminating the cataleptogenic effect of the typical neuroleptic haloperidol than amitriptyline. The absolute leaders in terms of thymoanaleptic properties under this technique are AZ-127 and AZ-128 compounds (p < 0.01 relative to amitriptyline and fluoxetine at each time point). Sample d02-20 also showed high activity, exceeding the efficacy of amitriptyline (p < 0.01 relative to amitriptyline at each time point), (the overall effectiveness is 47.64 % and 67.51 % higher than fluoxetine, respectively).
Conclusions. High antidepressant activity of alpha-cyanothioacetamide derivatives AZ-127, AZ-128, d02-20d02-26 was revealed.
Keywords
About the Authors
V. S. SubbotaLNR
Vladislav S. Subbota
291045, Lugansk, 50-letiya oborony Luganska qtr., 1g
E. Yu. Bibik
LNR
Elena Yu. Bibik, doctor of medical sciences, professor
291045, Lugansk, 50-letiya oborony Luganska qtr., 1g
S. G. Krivokolysko
LNR
Sergey G. Krivokolysko, doctor of chemical sciences, professor
291045, Lugansk, 50-letiya oborony Luganska qtr., 1g
291034, Lugansk, Molodezhny qtr., 20a
References
1. Subbota V.S., Bibik E.Yu. Potential biological targets for the creation of new antidepressant drugs. Morfologicheskiy al’manakh imeni V.G. Koveshnikova = Morphological almanac named after V.G. Koveshnikov. 2022;20(2):127–132. [In Russian].
2. Vazagaeva T.I., Akhapkin R.V., Alexandrovsky Yu.A. The role of brain-derived neurotrophic factor in mediating the action of antidepressants in the treatment of depression. Vestnik Rossiyskoy akademii meditsinskikh nauk = Annals of the Russian Academy of Medical Sciences. 2019;74(1):20–28. [In Russian]. doi: 10.15690/vramn1107
3. Miftakhova A.F., Nikitina I.L., Gabidullin R.A. Study of anti-depressive action mechanism of a new derivative of 1- (thietanyl-3) imidazoles in tests of neuropharmacological interaction. Meditsinskiy vestnik Bashkortostana = Medical Herald of Bashkrtostan. 2021;16(1):52–57. [In Russian].
4. Bochev A.V. Experimental preclinical study of analgesic activity of 3-cyano-1,4-dihydropyridines, cyanothioacetamide derivatives, in tail heat immersion test submerged in hot water. Dal’nevostochnyy meditsinskiy zhurnal = Far East Medical Journal. 2024;(2):45–49. [In Russian]. doi: 10.35177/1994-5191-2024-2-8
5. Bibik E.Yu., Nekrasa I.A., Demenko A.V., Frolov K.A., Dotsenko V.V., Krivokolysko S.G., Startseva A.S. Peculiarities of the effect of individual tetrahydropyrido[2,1-b][1,3,5]thiadiazine derivatives on the effects of levodopa in the tail suspension test. Kubanskiy nauchnyy meditsinskiy vestnik = Kuban Scientific Medical Bulletin. 2020;27(3):65–77. [In Russian]. doi: 10.25207/1608-6228-2020-27-3-65-77
6. Bibik E.Yu., Yaroshevskaya O.G., Devdera A.V., Demenko A.V., Zakharov V.V., Frolov K.A., Dotsenko V.V., Krivokolysko S.G. Search for anti-inflammatory agents in the tetrahydropyrido[2,1-b ][1,3,5]-thiadiazine series. Khimiko-farmatsevticheskiy zhurnal = Pharmaceutical Chemistry Journal. 2017;51(8):16–19. [In Russian]. doi: 10.1007/s11094-017-1669-1
7. Bibik E.Yu., Saphonova A.A., Yeryomin A.V., Frolov K.A., Dotsenko V.V., Krivokolysko S.G. Study of analeptic activity of tetrahydropyrido [2,1-b] [1,3,5] tiadiazine derivatives. Research Results in Pharmacology. 2017;3(4):20–25. doi: 10.18413/2313-8971-2017-34-20-25
8. Bibik E.Yu., Nekrasa I.A., Demenko A.V., Frolov K.A., Dotsenko V.V., Krivokolysko S.G. Studying the adaptogenic activity of a series of tetrahydropyrido[2,1-b] [1,3,5] thiadiazine derivatives. Byulleten’ sibirskoy meditsiny = Bulletin of Siberian Medicine. 2019;18(3):21–28. [In Russian]. doi: 10.20538/1682-0363-2019-3-21-28
9. Rice W.G., Turpin J.A., Schaeffer C.A., Graham L., Clanton D., Buckheit R.W., Zaharevitz D., Summers M.F., Wallqvist A., Covell D.G. Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel hiv-1 zinc finger inhibitors. J. Med. Chem. 1996;39(19):3606–3616. doi: 10.1021/jm960375o
10. Norman D.D., Ibezim A., Scott W.E., White S., Parrill A.L., Baker D.L. Autotaxin inhibition: Development and application of computational tools to identify site-selective lead compounds. Bioorg. Med. Chem. 2013;21(17):5548–5560. doi: 10.1016/j.bmc.2013.05.061
11. Guidelines for conducting preclinical studies of medicines. Moscow: Grif and K, 2012. 944 p. [In Russian].
12. Subbota V.S. Investigation of the anxiolytic effect of new dihydropyridine-2-thiols of cyanothioacetamide derivatives in the classical pharmacological test “dark-light chamber”. Modern achievements of chemical and biological sciences in preventive and clinical medicine: proc. conf., Saint-Petersburg, December 7–8, 2023. Saint-Petersburg: I.I. Mechnikov Northwestern State Medical University, 2023. 143–149. [In Russian].
13. Nekrasa I.A. An evaluation of antidepressant, adaptogenic and analeptic effects of selected tetrahydropyrido[2,1-b][1,3,5]thiadiazine derivatives: a review of the results of the own studies. Mezhdunarodnyy nauchno-issledovatel’skiy zhurnal = International Research Journal. 2023;(8):88. [In Russian]. doi: 10.23670/IRJ.2023.134.133
14. Garibova T.L., Kraineva V.A., Voronina T.A. Animal models of depression. Farmakokinetika i farmakodinamika = Pharmacokinetics and Pharmacodynamics. 2017;3:14–19. [In Russian].
15. Borozdenko D.A., Khovanova S.S., Kiseleva N.M., Negrebetsky V.V. Modeling depression. Rossiyskiy meditsinskiy zhurnal = Medical Journal of the Russian Federation. 2019;25(3):176–180. [In Russian]. doi: 10.18821/0869-2106-2019-25-3-176-180
16. Waldman E.A., Kraineva V.A., Kotelnikova S.O., Sadovsky M.S. The “learned helplessness” model in rats: possibilities and limitations in assessing a depressive-like state and effects of antidepressants. Biomeditsina = Biomedicine. 2021;17(2):22–34. [In Russian]. doi: 10.33647/2074-5982-17-2-22-34
17. Bocheva A.A., Bibik E.Yu., Krivokolysko S.G. Study of the analgesic activity of new partially hydrogenated pyridines, α-cyanothioacetamide derivatives in the pharmacological tail heat immersion test on white rats. Nauchno-meditsinskiy vestnik Tsentral’nogo Chernozem’ya = Scientific and Medical Bulletin of the Central Black Earth Region. 2023; 24(3):37–43. [In Russian]. doi: 10.18499/1990-472X-2023-24-3-37-43